Comparative evaluation of the efficacy, safety, and tolerability of rosuvastatin 10 mg with atorvastatin, 10 mg in adult patients with hypercholesterolaemia: The first Indian study

Journal of the Indian Medical Association

Volumn 102, Issue 1, 2004, Pages 48-52

  Jayaram, S ^a   Jain, M M ^b   Naikawadi, Akram A ^c   Gawde, Ashish ^d   Desai, Anish ^d  

^a BOMBAY HOSPITAL   (India)

^b GRANT MEDICAL COLLEGE   (India)

^c KBN Institute of Medical Sciences   (India)

^d Glenmark Pharmaceuticals Limited   (India)

Author keywords

Atorvastatin; Efficacy; Hypercholesterolaemia; LDL C; Rosuvastatin; Safety

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ATORVASTATIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL; FLUOROBENZENE; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; SULFONAMIDE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; INDIA; MALE; NAUSEA; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

APOLIPOPROTEINS B; CHOLESTEROL; FEMALE; FLUOROBENZENES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIMIDINES; PYRROLES; SULFONAMIDES;

EID: 3042621150     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Schneck DW, Knopp RH, Ballantyne CM, McPherson R, Chitra RR, Simonson SG - Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease. Am J Cardiol 2003; 91: 33-41.
2. Brown WV - Novel approaches to lipid lowering: what is on the horizon? Am J Cardiol 2001; 87: 23B-27B.
3. Knoop RH - Drug treatment of lipid disorders. N Engl J Med 1999; 341: 498-511.
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel II). JAMA 1993; 269: 3015-23.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
6. Jones-P, Kafonek S, Laurora I, Hunninghake D - Comparative dose, efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients of hypercholesterolemia (the CURVES study). Am J Cardiol 1998; 81: 582-7.
7. Davidson M, Ma P, Stein EA, Gotto AM Jr, Raza A, Chitra R, et al - Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia. Am J Cardiol 2002; 89: 268-75.
8. Olsson AG, Istad H, Luurila O, Ose L, Stender S, Tuomilehto J, et al - Rosuvastatin Investigators Group: effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia. Am Heart J 2002; 144: 1044-51.
9. Buckett L, Ballard P, Davidson R, et al - Selectivity of ZD 4522 for inhibition of cholesterol synthesis in hepatic versus non-hepatic cells. Atherosclerosis 2000; 151: 41.
10. McTaggart F, Buckett L, Davidson R, et al - Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am J Cardiol 2001; 87: 28B-32B.
11. Olsson AG - A new statin: a new standard. Clin Cardiol 2001; 24: 18-23.
12. Dart A, Jerums G, Nicholson G, et al - A multicenter, double-blind, 1-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Am J Cardiol 1997; 80: 39-44.
13. Farnier M, Portal JJ, Maigret P - Efficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemia. J Cardiovasc Pharmacol Ther 2000; 5: 27-32.
14. Fodor JG, Frohlich JJ, Genest JJG Jr, McPherson PR - Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. Can Med Assoc J 2000; 162: 1441-7.
15. Gotto AM Jr, Whitney E, Stein EA, Shapiro DR, Clearfield M, Weis S, et al - Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation 2000; 101: 477-84.
16. Walldius G, Jungner I, Holme I, Aastveit A, Kolar W, Steiner E - High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 2026-33.
17. Olsson AG, Pears J, McKellar J, et al - Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. Am J Cardiol 2001; 88: 504-8.
18. Jones PH, Davidson MH, Stein EA, et al - Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial). Am J Cardiol 2003; 92: 152-60.